Novo Nordisk (NOVOB DC) Wegovy pill recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class; to launch Wegovy pill in select markets outside US in H2 '26
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES